These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3814668

  • 21. Limited clinical utility of urinary MHPG.
    Lieber AL.
    Hillside J Clin Psychiatry; 1988; 10(1):98-104. PubMed ID: 3137145
    [Abstract] [Full Text] [Related]

  • 22. Urinary MHPG and clinical symptoms in patients with unipolar depression.
    Samson JA, Mirin SM, Griffin M, Borrelli D, Schildkraut JJ.
    Psychiatry Res; 1994 Feb; 51(2):157-65. PubMed ID: 8022950
    [Abstract] [Full Text] [Related]

  • 23. Urinary MHPG and clinical response to amitriptyline in depressed patients.
    Spiker DG, Edwards D, Hanin I, Neil JF, Kupfer DJ.
    Am J Psychiatry; 1980 Oct; 137(10):1183-7. PubMed ID: 7416262
    [Abstract] [Full Text] [Related]

  • 24. Urinary MHPG and ward behavior in unmedicated psychiatric patients.
    Mueser KT, Rosen AJ, Dysken MW, Javaid JI.
    Psychiatry Res; 1983 Dec; 10(4):275-83. PubMed ID: 6583716
    [Abstract] [Full Text] [Related]

  • 25. Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables.
    Kasper S, Beckmann H.
    Acta Psychiatr Scand; 1983 Jul; 68(1):31-7. PubMed ID: 6613617
    [Abstract] [Full Text] [Related]

  • 26. MHPG excretion in depression.
    Edwards DJ, Spiker DG, Neil JF, Kupfer DJ, Rizk M.
    Psychiatry Res; 1980 Jul; 2(3):295-305. PubMed ID: 6932069
    [Abstract] [Full Text] [Related]

  • 27. A clinical and biological validation of the DSM-III melancholia diagnosis in men: results of pattern recognition methods.
    Maes M, Maes L, Schotte C, Cosyns P.
    J Psychiatr Res; 1992 Jul; 26(3):183-96. PubMed ID: 1432845
    [Abstract] [Full Text] [Related]

  • 28. Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions.
    Rosenbaum AH, Maruta T, Schatzberg AF, Orsulak PJ, Jiang NS, Cole JO, Schildkraut JJ.
    Am J Psychiatry; 1983 Mar; 140(3):314-8. PubMed ID: 6829802
    [Abstract] [Full Text] [Related]

  • 29. Relationship between the dexamethasone suppression test and the L-tryptophan/competing amino acids ratio in depression.
    Maes M, De Ruyter M, Hobin P, Suy E.
    Psychiatry Res; 1987 Aug; 21(4):323-35. PubMed ID: 3628615
    [Abstract] [Full Text] [Related]

  • 30. Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process.
    Maes M, Bosmans E, Suy E, Minner B, Raus J.
    Br J Psychiatry; 1989 Dec; 155():793-8. PubMed ID: 2620206
    [Abstract] [Full Text] [Related]

  • 31. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls.
    Roy A, Guthrie S, Karoum F, Pickar D, Linnoila M.
    Arch Gen Psychiatry; 1988 Feb; 45(2):158-61. PubMed ID: 3337613
    [Abstract] [Full Text] [Related]

  • 32. Validation of four definitions of melancholia by the dexamethasone suppression test.
    Davidson J, Lipper S, Zung WW, Strickland R, Krishnan R, Mahorney S.
    Am J Psychiatry; 1984 Oct; 141(10):1220-3. PubMed ID: 6486256
    [Abstract] [Full Text] [Related]

  • 33. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
    Steiner M, Radwan M, Elizur A, Blum I, Atsmon A, Davidson S.
    Jpn J Exp Med; 1979 Apr; 49(2):95-9. PubMed ID: 480680
    [Abstract] [Full Text] [Related]

  • 34. Neuroendocrine and neurochemical measurements in depression.
    Davis KL, Hollister LE, Mathé AA, Davis BM, Rothpearl AB, Faull KF, Hsieh JY, Barchas JD, Berger PA.
    Am J Psychiatry; 1981 Dec; 138(12):1555-62. PubMed ID: 6171169
    [Abstract] [Full Text] [Related]

  • 35. Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?
    Miller KB, Nelson JC.
    Arch Gen Psychiatry; 1987 Sep; 44(9):769-74. PubMed ID: 3632250
    [Abstract] [Full Text] [Related]

  • 36. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings.
    Muscettola G, Potter WZ, Pickar D, Goodwin FK.
    Arch Gen Psychiatry; 1984 Apr; 41(4):337-42. PubMed ID: 6703853
    [Abstract] [Full Text] [Related]

  • 37. Alprazolam response in major depression: relationship with urinary levels of MHPG-sulfate.
    Gattaz WF, Bauer K, Rost W, Hübner CK, Müller WE.
    Pharmacopsychiatry; 1988 Nov; 21(6):374-5. PubMed ID: 3244771
    [No Abstract] [Full Text] [Related]

  • 38. Afternoon continuous plasma levels of 3-methoxy-4-hydroxyphenylglycol and age. Distinctive biologic subgroups of endogenous depression?
    Halbreich U, Sharpless N, Asnis GM, Endicott J, Goldstein S, Vital-Herne J, Eisenberg J, Zander K, Kang BJ, Shindledecker R.
    Arch Gen Psychiatry; 1987 Sep; 44(9):804-12. PubMed ID: 3632254
    [Abstract] [Full Text] [Related]

  • 39. Symptom profiles of biological markers in depression: a multivariate study.
    Maes M, Maes L, Suy E.
    Psychoneuroendocrinology; 1990 Sep; 15(1):29-37. PubMed ID: 2114648
    [Abstract] [Full Text] [Related]

  • 40. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A, Alcser K, Grunhaus L, Greden JF.
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.